Sufugolix (TAK-013) is a highly potent and orally available luteinizing hormone-releasing hormone ( LHRH ) receptor antagonist with an IC 50 of 0.1 nM.
Products | Products > Disease Areas > Metabolic or Endocrine Disease | Products > Signaling Pathways > GPCR/G Protein | Products > Research Areas > Endocrinology | Products > Signaling Pathways > GnRH Receptor
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.